Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Can looking at density differences between liver parenchyma and oligometastatic lesions predict outcomes and toxicities in patients receiving stereotactic body radiation therapy for metastatectomy? 2018 Gastrointestinal Cancers Symposium (GI-ASCO) Jin, W., Toesca, D. A., Osmundson, E., Shaffer, J. L., Koong, A. C., Chang, D. T. 2018: 479
View details for DOI 10.1200/JCO.2018.36.4_suppl.479